FindTrial
Sign In

Analysis of the effect of dietary magnesium supplementation on the improvement of blood glucose in elderly with prediabetes

Analysis of the effect of dietary magnesium supplementation on the improvement of blood glucose in elderly patients with prediabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047666
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes

Interventions

experimental group:Magnesium supplement
control group:Placebo supplement

Sponsors

National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. According to blood glucose level, it is prediabetes; 2. Over 60 years old; 3. BMI 18.5-28kg/m2; 4. Self care (self action, eating and communication); 5. Normal cognitive ability (MMSE score below mild).

Exclusion criteria

Exclusion criteria: 1. Related diseases affecting gastrointestinal absorption; 2. Abnormal renal function; 3. Abnormal liver function; 4. Cardiovascular and cerebrovascular diseases: in the acute stage of cardiovascular and cerebrovascular diseases, acute coronary syndrome (one month before the study); 5. Malignant tumor; 6. Participate in other clinical trials; 7. Recently taken (1 month before the study) or taking pure magnesium supplement.

Design outcomes

Primary

MeasureTime frame
glucose;—

Countries

China

Contacts

Public ContactYang Lichen

National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention

yanglc@ninh.chinacdc.cn+86 13683341260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026